Covid-19
DiaSorin Gets FDA Emergency-Use Rights for Covid-19 Test in U.S.
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
DiaSorin SpA received Emergency Use Authorization from the U.S. Food and Drug Administration for a new serologic test for Covid-19.